妥舒沙星、替马沙星和A-56620对腹泻病原体的体外活性
In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea.
作者信息
Bryan J P, Waters C, Sheffield J, Krieg R E, Perine P L, Wagner K
机构信息
Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, Bethesda, Maryland.
出版信息
Antimicrob Agents Chemother. 1990 Feb;34(2):368-70. doi: 10.1128/AAC.34.2.368.
Abstract
Tosufloxacin (A-60969 HCl), a new quinolone with broad activity against gram-positive and anaerobic organisms, was compared in vitro with other quinolones against bacterial pathogens of diarrhea. Tosufloxacin was the most active agent against Salmonella spp., Shigella spp., Campylobacter spp., Aeromonas hydrophila, and Vibrio spp. Temafloxacin (A-62254) also demonstrated good activity against these organisms.
摘要
托氟沙星（盐酸A-60969）是一种对革兰氏阳性菌和厌氧菌具有广泛活性的新型喹诺酮类药物，在体外将其与其他喹诺酮类药物针对腹泻病原菌进行了比较。托氟沙星对沙门氏菌属、志贺氏菌属、弯曲菌属、嗜水气单胞菌和弧菌属是活性最强的药物。替马沙星（A-62254）对这些菌也显示出良好活性。
相似文献
1
In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea.妥舒沙星、替马沙星和A-56620对腹泻病原体的体外活性
Antimicrob Agents Chemother. 1990 Feb;34(2):368-70. doi: 10.1128/AAC.34.2.368.
2
The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.新型氟喹诺酮类药物托氟沙星与环丙沙星和替马沙星的体外活性比较。
J Antimicrob Chemother. 1991 Nov;28(5):719-25. doi: 10.1093/jac/28.5.719.
3
In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.替马沙星、托氟沙星（A-61827）及其他五种氟喹诺酮类药物的体外活性
J Antimicrob Chemother. 1989 Apr;23(4):527-35. doi: 10.1093/jac/23.4.527.
4
In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea.洛美沙星和替马沙星对引起腹泻病原体的体外活性
Antimicrob Agents Chemother. 1989 Aug;33(8):1385-7. doi: 10.1128/AAC.33.8.1385.
5
In vitro activity of tosufloxacin against bacterial enteric pathogens.
Diagn Microbiol Infect Dis. 1990 Jul-Aug;13(4):333-6. doi: 10.1016/0732-8893(90)90026-r.
6
In-vitro activity of tosufloxacin, a new quinolone antibacterial agent.
J Antimicrob Chemother. 1992 Jun;29(6):639-47. doi: 10.1093/jac/29.6.639.
7
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.十二种4-喹诺酮类抗菌药物对肠道病原体的体外活性比较
Drugs Exp Clin Res. 1985;11(4):253-7.
8
Comparative in vitro activity of the new difluoro-quinolone temafloxacin (A-62254) against bacterial isolates from cancer patients.新型二氟喹诺酮替马沙星（A-62254）对癌症患者分离出的细菌的体外活性比较
Eur J Clin Microbiol Infect Dis. 1988 Oct;7(5):684-6. doi: 10.1007/BF01964255.
9
In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin.司帕沙星、妥舒沙星、环丙沙星和氟罗沙星的体外活性。
Antimicrob Agents Chemother. 1991 May;35(5):955-60. doi: 10.1128/AAC.35.5.955.
10
Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.新型喹诺酮类药物Bay y 3118与环丙沙星、司帕沙星、妥舒沙星、CI-960和CI-990的体外活性比较
J Antimicrob Chemother. 1993 Apr;31(4):505-22. doi: 10.1093/jac/31.4.505.
引用本文的文献
1
In vitro activities of cephalosporins and quinolones against Escherichia coli strains isolated from diarrheic dairy calves.头孢菌素和喹诺酮类药物对从腹泻乳牛犊分离出的大肠杆菌菌株的体外活性。
Antimicrob Agents Chemother. 1999 Mar;43(3):510-3. doi: 10.1128/AAC.43.3.510.
2
Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni.多重耐药空肠弯曲杆菌中存在外排泵的证据。
Antimicrob Agents Chemother. 1995 Sep;39(9):2019-22. doi: 10.1128/AAC.39.9.2019.
3
Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations.空肠弯曲菌gyrA基因的克隆、核苷酸序列及喹诺酮耐药性突变的特征分析
Antimicrob Agents Chemother. 1993 Mar;37(3):457-63. doi: 10.1128/AAC.37.3.457.
4
In vitro activities of enoxacin, enrofloxacin, sparfloxacin, and ciprofloxacin against Escherichia coli strains isolated from diarrheic lambs and kids.依诺沙星、恩诺沙星、司帕沙星和环丙沙星对从腹泻羔羊和幼崽分离出的大肠杆菌菌株的体外活性。
Antimicrob Agents Chemother. 1994 Oct;38(10):2469-70. doi: 10.1128/AAC.38.10.2469.
5
In vitro antimicrobial susceptibilities of Yersinia enterocolitica and related species isolated from slaughtered pigs and pork products.从屠宰猪和猪肉产品中分离出的小肠结肠炎耶尔森菌及相关菌种的体外抗菌药敏性
Antimicrob Agents Chemother. 1990 Dec;34(12):2423-5. doi: 10.1128/AAC.34.12.2423.
6
Characterization of high-level quinolone resistance in Campylobacter jejuni.空肠弯曲菌中高水平喹诺酮耐药性的特征分析
Antimicrob Agents Chemother. 1991 May;35(5):840-5. doi: 10.1128/AAC.35.5.840.
7
Future directions in antimicrobial chemotherapy.抗菌化疗的未来发展方向。
Pharm Weekbl Sci. 1992 Aug 21;14(4A):229-44. doi: 10.1007/BF01962545.
本文引用的文献
1
Campylobacter enteritis in the United States. A multicenter study.美国弯曲杆菌肠炎：一项多中心研究
Ann Intern Med. 1983 Mar;98(3):360-5. doi: 10.7326/0003-4819-98-3-360.
2
Erythromycin-resistant Campylobacter infections in Thailand.泰国的红霉素耐药弯曲杆菌感染
Antimicrob Agents Chemother. 1987 Mar;31(3):438-42. doi: 10.1128/AAC.31.3.438.
3
Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea.环丙沙星与安慰剂治疗细菌性腹泻的临床疗效比较。
Am J Med. 1987 Apr 27;82(4A):329-32.
4
Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial.环丙沙星或复方新诺明作为旅行者腹泻的初始治疗：一项安慰剂对照随机试验
Ann Intern Med. 1987 Feb;106(2):216-20. doi: 10.7326/0003-4819-106-2-216.
5
Problems in salmonellosis: rationale for clinical trials with newer beta-lactam agents and quinolones.
Rev Infect Dis. 1986 Mar-Apr;8(2):189-207. doi: 10.1093/clinids/8.2.189.
6
Efficacy of ciprofloxacin in the treatment of chronic typhoid carriers.环丙沙星治疗慢性伤寒带菌者的疗效
J Infect Dis. 1988 Jun;157(6):1235-9. doi: 10.1093/infdis/157.6.1235.
7
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).新型氟化4-喹诺酮T-3262（A-60969）的体外活性比较
Antimicrob Agents Chemother. 1988 May;32(5):663-70. doi: 10.1128/AAC.32.5.663.
8
Use of norfloxacin to treat chronic typhoid carriers.使用诺氟沙星治疗慢性伤寒带菌者。
J Infect Dis. 1988 Jun;157(6):1221-5. doi: 10.1093/infdis/157.6.1221.
9
Antimicrobial therapy for enteric infections and typhoid fever: state of the art.肠道感染和伤寒的抗菌治疗：最新进展
Rev Infect Dis. 1988 Jan-Feb;10 Suppl 1:S199-205. doi: 10.1093/clinids/10.supplement_1.s199.
10
Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.氨曲南、环丙沙星、诺氟沙星、氧氟沙星、HR 810（一种新型头孢菌素）、RU28965（一种新型大环内酯类药物）及其他药物对肠道病原体的体外比较活性。
Antimicrob Agents Chemother. 1985 Mar;27(3):388-92. doi: 10.1128/AAC.27.3.388.
Zotero 插件